MolNFT v1 · #138147 · protein
Toxoplasma gondii CDPK1 in complex with inhibitor LJQ138
5W9R · Calmodulin-domain protein kinase 1: “Toxoplasma gondii CDPK1 in complex with inhibitor LJQ138”. X-ray diffraction, 1 ligand (9YG), 5 pockets (best druggability 0.77). MolNFT v1 #138147 on GenesisL1: 3D structure, binding sites and…
- PDB
- 5W9R
- Type
- protein
- Length
- 445 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Calmodulin-domain protein kinase 1
- UniProt
- Q9BJF5
- Ligands
- 9YG
- Pockets
- 5 · best druggability 0.77
Structure
x-ray diffraction · 1 distinct chain · 52% helix, 12% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Calmodulin-domain protein kinase 1 | protein | 445 | 52% helix, 12% strand | Q9BJF5 |
Ligands and binding sites
- 9YG · 1-tert-butyl-3-[(1H-indol-3-yl)methyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 302 | 0.77 | 0.88 | 43 | 9YG |
| 2 | 808 | 0.75 | 0.79 | 88 | empty |
| 3 | 62 | 0.68 | 0.95 | 15 | empty |
| 4 | 66 | 0.32 | 0.75 | 16 | empty |
| 5 | 60 | 0.30 | 0.75 | 16 | empty |
Compared structures
- 5W9R · Toxoplasma Gondii CDPK1 in complex with inhibitor LJQ138 · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9BJF5
- Elsewhere: RCSB PDB 5W9R · PDBe 5W9R · UniProt Q9BJF5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.